Transcode Therapeutics, Inc.

Ownership Transactions Reported by 7 Insiders

Symbol
RNAZ on Nasdaq
Industry
Pharmaceutical Preparations
Location
6 Liberty Square, #2382, Boston, MA

There are no Buy or Sell transactions made by insiders since 11/4/2023

Transcode Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Anna Moore 10%+ Owner $792K Jul 8, 2021
Robert Michael Dudley Chief Executive Officer, Director $91.9K Sep 28, 2023
Thomas A. Fitzgerald Interim CEO, CFO, Director $28.7K Jun 14, 2024
Philippe Calais Director Jun 14, 2024
Zdravka Medarova Chief Technology Officer, 10%+ Owner Dec 12, 2022
Erik Manting Director Jun 14, 2024
Magda Marquet Director Jun 14, 2024

Recent Insider Transactions by Companies or Individuals for Transcode Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.